fermentek

 

Fermentek homepage
about
products
contact us

Resources

Wada K, Takada M, Kotake T, Ochi H, Morishita H, Komamura K, Oda N, Mano A, Kato TS, Hanatani A, Nakatani T.

Circ J. 2007 Jul;71(7):1022-8.

Limited sampling strategy for mycophenolic acid in Japanese heart transplant recipients: comparison of cyclosporin and tacrolimus treatment.

Department of Pharmacy, National Cardiovascular Center, Fujishirodai, Suita, Japan. kwada@hsp.ncvc.go.jp

BACKGROUND: The purpose of the study was to characterize the pharmacokinetics of mycophenolic acid (MPA) in Japanese heart transplant recipients and to find the time point that has the best correlation with the MPA area under the plasma concentration curve (AUC). METHODS AND RESULTS: Twenty-two Japanese recipients treated with mycophenolate mofetil were evaluated in the study. Approximately 9 months after transplantation, the area under the MPA serum concentration-time curve from 0 to 12 h (AUC(0-12 h)) was evaluated. The MPA AUC(0-12 h) h values in the cyclosporine (CsA) and tacrolimus (FK) groups ranged from 13.11 to 50.98 mug . h/ml and from 39.19 to 93.18 mug . h/ml, respectively. Fourteen models were developed and analyzed for their ability to estimate the MPA AUC(0-12 h) based on a limited number of samples in the CsA group. Sixteen models were developed in the FK group. The best model for predicting the full MPA AUC(0-12 h) in the CsA group was a 3-time-point model that included C(0 h), C(1 h) and C(2 h) (r(2), 0.96; mean prediction error, 0.15+/-7.85%); a 2-time-point model that included C(0 h), and C(2 h) (r(2), 0.94; mean prediction error, 0.495+/-10.35%) was also reliable. In the FK group, a 3-time-point model that included C(1 h), C(2 h) and C(4h) (r(2), 0.73; mean prediction error, 2.73+/-17.09%) was the best model for predicting the full MPA AUC(0-12 h), but it was not reliable in clinical practice. CONCLUSION: A 3-(C(0 h), C(1 h) and C(2 h)) and a 2-time-point model (C(0 h) and C(2 h)) are useful for predicting the full MPA AUC(0-12 h) in Japanese heart transplant recipients treated with CsA but not with FK.
 

PMID: 17587705

 Free Full Text

back to product page

 
fermentek  

Sitemap
Home Products Hebrew About us ISO GMP/API Mad cow GMO | Sales policy Receiving RFQ OrderingContact webmaster Ask scientist Contact sales  |
Privacy About website Copyright

Products
7AAD 17AAG 17DMAG A23187, 4-Bromo A23187, Ca/ Mg salt A23187 (free acid) Actinomycin D Aflatoxin B1 Aflatoxin B2 Aflatoxin G1 Aflatoxin G2 Aflatoxin M1 Aflatoxin M2 Alamethicin Anisomycin Apicidin Aphidicolin Ascomycin Bafilomycin A1 Brefeldin A castanospermine Cerulenin Chelerythrine Chromomycin A3 Citrinin Cyclopiazonic acid Cytochalasin A Cytochalasin B Cytochalasin C Cytochalasin D Cytochalasin E Dihidrocytochalasin Deoxynivalenol FK506 Forskolin Fumagillin Fumonisin B1 Fumonisin B2 Geldanamycin Genistein Gliotoxin Hypericin HT2 toxin Ionomycin Ca K252A K252B KT5720 KT5823 Leptomycin B Mithramycin A Mitomycin C Moniliformin Mycophenolic Myriocin Nigericin Nonactin Ochratoxin A Oligomycin Oligomycin A Oligomycin B Parthenolide Patulin Paxilline Penicillic acid Penitrem A PKC412 Puromycin Puromycin AN Radicicol Rapamycin Staurosporine Sirolimus Sterigmatocystin T2 toxin Taxol Tentoxin Thapsigargin Thiolutin Triacsin Trichostatin Tunicamycin Valinomycin Verruculogen Vomitoxin Withaferin A Wortmannin Zearalenone


unique visitor counter
 
Company's eMail: 

Anti-spam measures have been taken here. Please copy this address into your eMail software. We are sorry for the inconvenience.

Mail Address:

Yatziv 25, POB 47120, Jerusalem 97800 Israel

Phone: 972 2 5853953

Fax: 972 2 5853943


 

 

 

 

My Green Corner spam safe site

ab, abh

--

ZZZ from Fermentek for sale